Bio-Rad Laboratories (NYSE:BIO) Posts Earnings Results, Misses Estimates By $0.54 EPS

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) announced its quarterly earnings results on Thursday. The medical research company reported $2.33 EPS for the quarter, missing the consensus estimate of $2.87 by ($0.54), Briefing.com reports. Bio-Rad Laboratories had a negative net margin of 5.86% and a positive return on equity of 3.82%. The firm had revenue […]

Related Keywords

Canada ,Bridgewater ,Nova Scotia ,United States ,America ,Timothys Ernst , ,Kolinsky Wealth Management ,Delphia United States Inc ,Mather Group ,Wells Fargo Company ,Royal Bank ,Bridgewater Associates ,Ep Wealth Advisors ,Bio Rad Laboratories Company Profile ,Bio Rad Laboratories Inc ,Credit Suisse Group ,Bio Rad Laboratories ,Get Free Report ,Rad Laboratories ,Rad Laboratories Trading Down ,Suisse Group ,Wealth Management ,Delphia United States ,Life Science ,Clinical Diagnostics ,Bio Rad Laboratories Daily ,Nyse Bio ,Bio ,Medical ,09057220 ,Earnings ,